APOLLO AP39 LIMITED
Company number 14395980 · Monitor this company
20 filings
| Date | Filing | |
|---|---|---|
| 4 Aug 2026 | PARENT_ACC · 37 pages | View document |
| 4 Aug 2026 | AGREEMENT2 · 1 page | View document |
| 4 Aug 2026 | GUARANTEE2 · 3 pages | View document |
| 4 Aug 2026 | Audit exemption subsidiary accounts made up to 2025-12-31 · 12 pages | View document |
| 7 Oct 2025 | Confirmation statement made on 2025-10-03 with no updates · 3 pages | View document |
| 11 Sep 2025 | Audit exemption subsidiary accounts made up to 2024-12-31 · 12 pages | View document |
| 11 Sep 2025 | GUARANTEE2 · 2 pages | View document |
| 11 Sep 2025 | PARENT_ACC · 35 pages | View document |
| 11 Sep 2025 | AGREEMENT2 · 1 page | View document |
| 10 Jan 2025 | Appointment of Jamie Heath as a director on 2025-01-07 · 2 pages | View document |
| 4 Oct 2024 | Confirmation statement made on 2024-10-03 with no updates · 3 pages | View document |
| 3 Jul 2024 | Audit exemption subsidiary accounts made up to 2023-12-31 · 12 pages | View document |
| 3 Jul 2024 | AGREEMENT2 · 1 page | View document |
| 3 Jul 2024 | GUARANTEE2 · 3 pages | View document |
| 3 Jul 2024 | PARENT_ACC · 36 pages | View document |
| 4 Oct 2023 | Confirmation statement made on 2023-10-03 with updates · 5 pages | View document |
| 24 Feb 2023 | Change of details for Apollo Therapeutics Limited as a person with significant control on 2023-02-24 · 2 pages | View document |
| 24 Feb 2023 | Registered office address changed from 24 Hills Road Cambridge CB2 1JP United Kingdom to 3rd Floor 22 Station Road Cambridge CB1 2JD on 2023-02-24 · 1 page | View document |
| 6 Oct 2022 | Current accounting period extended from 2023-10-31 to 2023-12-31 · 1 page | View document |
| 4 Oct 2022 | Incorporation · 55 pages | View document |